Immuno-oncology Biostatistics : PD-1 vs PD-L1 domain specific knowledge and advice both both Biostatisticians and Researchers working in this field is the main topic in this article. Thanks for reading and happy learning!
In this article, i disccuss the specificities of using PFS and TTP in Oncology trials and Oncology RWE. Both Statistical and Biological features and methodologies are discussed
RECIST methodology is one of the most important frameworks for assesing the non-operable tumor progression, but is not limited to that field. In this article, i discuss both the Biological and Statistical aspects of RECIST
darkomedin@gmail.com
For collaboration purposes, feel free to contact me using the links above
